Frequency of Human Endogenous Retroviral Sequences (HERV) K113 and K115 in the Polish Population, and Their Effect on HIV Infection

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Zwolińska, Katarzyna ^a   Knysz, Brygida ^b   Gasiorowski, Jacek ^b   Pazgan Simon, Monika ^b   Gładysz, Andrzej ^b   Sobczyński, Maciej ^c   Piasecki, Egbert ^a,d  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

^c UNIVERSITY OF WROC AW   (Poland)

^d JAN DLUGOSZ UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHILD; CONTROLLED STUDY; ENDOGENOUS RETROVIRUS; FEMALE; HUMAN; HUMAN ENDOGENOUS RETROVIRAL SEQUENCE K113; HUMAN ENDOGENOUS RETROVIRAL SEQUENCE K115; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFECTION SENSITIVITY; LONG TERMINAL REPEAT; MAJOR CLINICAL STUDY; MALE; POLAND; PRESCHOOL CHILD; PREVALENCE; SEQUENCE ANALYSIS; VIRUS DETECTION;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DNA, VIRAL; ENDOGENOUS RETROVIRUSES; FEMALE; FOLLOW-UP STUDIES; HIV; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; POLAND; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROGNOSIS; YOUNG ADULT;

EID: 84886616544     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077820     Document Type: Article

References (53)

1. Belshaw R, Pereira V, Katzourakis A, Talbot G, Pačes J, et al. (2004) Long-term reinfection of the human genome by endogenous retrovirus. Proc Natl Acad Sci USA 101: 4894-4899.
2. Nelson PN, Carnegie PR, Martin J, Davari Ejtehadi H, Hooley P, et al. (2003) Demystified. Human endogenous retroviruses. J Clin Pathol: Mol Pathol 56: 11-18.
3. Zwolińska K, (2006) Retroviruses-derived sequences in the human genome Human endogenous retroviruses (HERVs). Postepy Hig Med Dosw 60: 637-652.
4. Bannert N, Kurth R, (2004) Retroelements and the human genome: New perspective on an old relation. Proc Natl Acad Sci USA 101: 14572-14579.
5. Jha AR, Nixon DF, Rosenberg MG, Martin JN, Deeks SG, et al. (2011) Human endogenous retrovirus K106 (HERV-K106) was infectious after the emergence of anatomically modern humans. PLoS One 6: e20234.
6. Tristem M, (2000) Identification and characterisation of novel human endogenous retrovirus families by phylogenetic screening of the human genome mapping project database. J Virol 74: 3715-3730.
7. Bock M, Stoye JP, (2000) Endogenous retroviruses and the human germline. Div Virol 10: 651-655.
8. Zwolińska K, (2009) Host genetic factors associated with susceptibility to HIV infection and progression of infection. Postepy Hig Med Dosw 63: 73-91.
9. Muir A, Lever A, Moffett A, (2004) Expression and functions of human endogenous retroviruses in the placenta: an update. Placenta 18: 16-25.
10. Pačes J, Huang YT, Pačes V, Rídl J, Chang CM, (2013) New insight into transcription of human endogenous retroviral elements. N Biotechnol 25: 314-318.
11. Lee YN, Bieniasz PD, (2007) Reconstitution of an infectious human endogenous retrovirus. PLoS Pathog 3: 119-130.
12. Garrison KE, Jones RB, Meiklejohn DA, Anwar N, Ndhlovu LC, et al. (2007) T cell responses to human endogenous retroviruses in HIV-1 infection. PLoS Pathog 3: 1617-1627.
13. Lavie L, Kitova M, Maldener E, Meese E, Mayer J, (2005) CpG methylation directly regulates transcriptional activity of the human endogenous retrovirus family HERV-K(HML-2). J Virol 79: 876-883.
14. Moyes D, Griffiths DJ, Venables PJ, (2007) Insertional polymorphisms: a new lease of life for endogenous retroviruses in human disease. Trends Genet 23: 326-333.
15. Contreras-Galindo R, Kaplan MH, Markovitz DM, Lorenzo E, Yamamura Y, (2006) Detection of HERV-K (HML-2) viral RNA in plasma of HIV type 1-infected individuals. AIDS Res Human Retroviruses 22: 979-984.
16. Boller K, Schönfeld K, Lischer S, Fischer N, Hoffman A, et al. (2008) Human endogenous retrovirus HERV-K113 is capable of producing intact viral particles. J Gen Virol 89: 567-572.
17. Christensen T, (2010) HERVs in neuropathogenesis. J Neuroimmune Pharmacol 5: 326-335.
18. Clausen J, (2003) Endogenous retroviruses and MS: using ERVs as disease markers. Int MS J 10: 22-28.
19. Moyes DL, Martin A, Sawcer S, Temperton N, Worthington J, et al. (2005) The distribution of the endogenous retroviruses HERV-K113 and HERV-K115 in health and disease. Genomics 86: 337-341.
20. de la Hera B, Varadé J, García-Montojo M, Lamas JR, de la Encarnación A, et al. (2013) Role of the human endogenous retrovirus HERV-K18 in autoimmune disease susceptibility: study in the Spanish population and meta-analysis. PLoS One. 8: e62090.
21. Zawada M, (2012) Potential pathogens in multiple sclerosis (MS). Postepy Hig Med Dosw 22: 758-770.
22. Freimanis G, Hooley P, Davari Ejtehadi H, Ali HA, Veitch A, et al. (2010) A role for human endogenous retrovirus-K (HML-2) in rheumatoid arthritis: investigating mechanisms of pathogenesis. Clin Exp Immunol 160: 340-347.
23. Reynier F, Verjat T, Turrel F, Imbert PE, Marotte H, et al. (2009) Increase in human endogenous retrovirus HERV-K (HML-2) viral load in active rheumatoid arthritis. Scand J Immunol 70: 295-299.
24. Nelson PN, Hooley P, Roden D, Davari Ejtehadi H, Ali HA, et al. (2004) Human endogenous retroviruses: transposable elements with potential. Clin Exp Immunol 138: 1-9.
25. Molès JP, Tesniere A, Guilhou JJ, (2005) A new endogenous retroviral sequence is expressed in skin of patients with psoriasis. Brit J Derm 153: 83-89.
26. Burmeister T, Ebert AD, Pritze W, Loddenkemper C, Schwartz S, et al. (2004) Insertional polymorphisms of endogenous HERV-K113 and HERV-K115 retroviruses in breast cancer patients and age-matched controls. AIDS Res Human Retroviruses 20: 1223-1229.
27. Lee WJ, Kwun HJ, Kim HS, Jang KL, (2003) Activation of the human endogenous retrovirus W long terminal repeat by herpes simplex virus type 1 immediate early protein 1. Mol Cells 28: 75-80.
28. Turcanova VL, Bundgaard B, Hollsberg P, (2009) Human herpesvirus-6B induces expression of the human endogenous retrovirus K18-encoded superantigen. J Clin Virol 46: 15-19.
29. Tai AK, Luka J, Ablashi D, Huber BT, (2009) HHV-6A infection induces expression of HERV-K18-encoded superantigen. J Clin Virol 46: 47-48.
30. Otowa T, Tochigi M, Rogers M, Umekage T, Kato N, et al. (2006) Insertional polymorphism of endogenous retrovirus HERV-K115 in schizophrenia. Neurosci Lett 20: 226-229.
31. van der Kuyl AC, (2012) HIV infection and HERV expression a review. Retrovirology 16: 6.
32. An DS, Xie YM, Chen ISY, (2001) Envelope gene of the human endogenous retrovirus HERV-W encodes a functional retrovirus envelope. J Virol 75: 3488-3489.
33. Padow M, Lai L, Fisher RJ, Zhou YC, Wu X, et al. (2000) Analysis of human immunodeficiency virus type 1 containing HERV-K protease. AIDS Res Human Retroviruses 16: 1973-1980.
34. Towler EM, Gulnik SV, Bhat TN, Xie D, Gustschina E, et al. (1998) Functional characterisation of the protease of human endogenous retrovirus, K10: can it complement HIV-1 protease? Biochemistry 37: 17137-17144.
35. Mayer J, Ehlhardt S, Seifert M, Sauter M, Müeller-Lantzsch N, et al. (2004) Human endogenous retrovirus HERV-K(HML-2) proviruses with Rec protein coding capacity and transcriptional activity. Virology 322: 190-198.
36. Contreras-Galindo R, López P, Vélez R, Yamamura Y, (2007) HIV-1 infection increases the expression of human endogenous retroviruses type K (HERV-K) in vitro. AIDS Res Human Retroviruses 23: 116-122.
37. Yang J, Bogerd HP, Peng S, Wiegard H, Truant R, et al. (1999) An ancient family of human endogenous retroviruses encodes a functional homolog of the HIV-1 Rev protein. Proc Natl Acad Sci USA 96: 13404-13408.
38. Macfarlane C, Simmonds P, (2004) Allelic variation of HERV-K(HML-2) endogenous retroviral elements in human population. J Mol Evol 59: 642-656.
39. Jha AR, Pillai SK, York VA, Sharp ER, Storm EC, et al. (2009) Cross-sectional dating of novel haplotypes of HERV-K 113 and HERV-K 115 indicate these proviruses originated in Africa before Homo sapiens. Mol Biol Evol 26: 2617-2626.
40. Zwolińska K, Knysz B, Rybka K, Pazgan-Simon M, Ga{ogonek}siorowski J, et al. (2013) Protective effect of CCR5-Δ32 against HIV infection by the heterosexual mode of transmission in a Polish population. AIDS Res Human Retroviruses 29: 54-60.
41. Malassiné A, Blaise S, Handschuh K, Lalucque H, Dupressoir A, et al. (2007) Expression of the fusogenic HERV-FRD Env glycoprotein (syncytin 2) in human placenta is restricted to villous cytotrophoblastic cells. Placenta 28: 185-191.
42. Yi JM, Kim HM, Kim HS, (2006) Human endogenous retrovirus HERVH family in human tissues and cancer cells: expression, identification, and phylogeny. Cancer Lett 231: 228-239.
43. Noorali S, Rotar IC, Lewis C, Pestaner JP, Pace DG, et al. (2009) Role of HERV-W syncytin-1 in placentation and maintenance of human pregnancy. Appl Immunohistochem Mol Morphol 17: 319-328.
44. Krzysztalowska-Wawrzyniak M, Ostanek M, Clark J, Binczak-Kuleta A, Ostanek L, et al. (2011) The distribution of human endogenous retrovirus K-113 in health and autoimmune diseases in Poland. Rheumatology 50: 1310-1314.
45. Mullins CS, Linnebacher M, (2012) Human endogenous retroviruses and cancer: causality and therapeutic possibilities. World J Gastroenterol 18: 6027-6035.
46. Cegolon L, Salata C, Weiderpass E, Vineis P, Palù G, et al. (2013) Human endogenous retroviruses and cancer prevention: evidence and prospects. BMC Cancer 13: 4.
47. Contreras-Galindo R, Kaplan MH, Contreras-Galindo AC, Gonzalez-Hernandez MJ, Ferlenghi I, et al. (2012) Characterization of human endogenous retroviral elements in the blood of HIV-1-infected individuals. J Virol 86: 262-276.
48. Gonzalez-Hernandez MJ, Swanson MD, Contreras-Galindo R, Cookinham S, King SR, et al. (2012) Expression of human endogenous retrovirus type K (HML-2) is activated by the Tat protein of HIV-1. J Virol 86: 7790-7805.
49. Ormsby CE, Sengupta D, Tandon R, Deeks SG, Martin JN, et al. (2012) Human endogenous retrovirus expression is inversely associated with chronic immune activation in HIV-1 infection. PLoS One 7: e41021.
50. Contreras-Galindo R, Gonzàlez M, Almodovar-Camacho S, Gonzàlez-Ramìrez S, Yamamura Y, (2006) A new Real-Time-RT-PCR for quantitation of human endogenous retroviruses type K (HERV-K) RNA load in plasma samples: increased HERV-K RNA titers in HIV-1 patients with HAART non-suppressive regimens. J Virol Methods 136: 51-57.
51. Indik S, Günzburg WH, Salmos B, Rouault F, (2005) A novel, mouse mammary tumor virus encoded protein with Rev-like properties. Virology 337: 1-6.
52. Turner G, Barbulescu M, Su M, Jensen-Seaman MJ, Kidd KK, et al. (2001) Insertional polymorphisms of full length endogenous retroviruses in humans. Curr Biol 11: 1531-1535.
53. Monde K, Contreras-Galindo R, Kaplan MH, Markovitz DM, Ono A, (2012) Human endogenous retrovirus K Gag coassembles with HIV-1 Gag and reduces the release efficiency and infectivity of HIV-1. J Virol 86: 11194-11208.